MYX 3.05% $4.73 mayne pharma group limited

Ann: Class action settlement, page-20

  1. 8 Posts.
    lightbulb Created with Sketch. 1
    This looks over sold to me.
    I was a long term holder and sold out a few months back (at around $6.40/share).
    It now looks like a buy. Especially if H2 revenue has a similar increase as the recent half year results.
    Today's settlement removes the risk/uncertainty associated with the Class Action.
    I've been buying today.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.